The incidence of autoimmune diseases is increasing. Antinuclear antibody (ANA) testing is a
critical tool for their diagnosis. However, ANA prevalence in healthy persons has increased …

Anti-DFS70 antibodies have been proposed as a marker to exclude systemic autoimmune
rheumatic disease (SARD). We conducted this systematic diagnostic test accuracy review …

Background Indirect immunofluorescence (IIF) is the most prevalent screening antinuclear
antibody test for systemic autoimmune rheumatic disease (SARD). Certain IIF patterns have …

Summary Background and Objectives Antinuclear antibodies (ANA) detected by HEp2 cell
immunofluorescence staining are a characteristic finding in patients with connective tissue …

The diagnosis of systemic autoimmune rheumatic disease (SARD) or its exclusion is carried
out taking into account the results of immunological studies, primarily antinuclear antibodies …

Introduction Anti-DFS70 antibodies occur in healthy individuals with various medical
conditions. Unlike other anti-nuclear autoantibodies (ANA), they are not associated with …

Monospecific anti-DFS70 antibodies are moderately helpful in excluding ANA-associated
rheumatic disease in patients presenting with a dense fine speckled pattern - A systematic …

Objective To explore the effect of anti‐nuclear antibodies (ANAs) on the outcome of in vitro
fertilization‐embryo transplantation (IVF‐ET) and to study the effect of ANAs in follicular fluid …

Background Screening for antinuclear antibodies (ANA) by indirect immunofluorescence
(IIF) on HEp-2 cells is helpful for the diagnosis and classification of ANA-associated …

The presence of monospecific dense fine speckled 70 (DFS70) pattern in indirect
immunofluorescence assay (IFA) without concomitant systemic autoimmune related …